Anzeige
Mehr »
Login
Dienstag, 05.11.2024 Börsentäglich über 12.000 News von 674 internationalen Medien
300% Aktienanstieg war nur der Vorgeschmack – Warum diese Kupferstory noch besser wird!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
152 Leser
Artikel bewerten:
(1)

GES To Be Acquired by Truelink Capital

Transaction Supports Accelerated Growth

LAS VEGAS and LOS ANGELES, Oct. 21, 2024 /PRNewswire/ -- GES, a leading provider in the global exhibition and event industry, announced today that its parent company, Viad Corp, and Truelink Capital, a Los Angeles based private equity firm, have entered into a definitive agreement whereby Truelink will acquire the GES business. The acquisition is expected to close by the end of 2024, subject to applicable and customary closing conditions.

The GES business entity is a dynamic collective of industry-leading companies and their distinctive specialties-GES Exhibitions, Spiro, onPeak, SHOWTECH and Visit-that deliver comprehensive experiential, strategic, creative, event management and accommodation, meeting planning and logistical solutions, as well as registration and engagement solutions.

Derek Linde, GES President said, "This is an exciting time for GES. The business has tremendous momentum, and our team is driving strong revenue growth, margin expansion, and client service. The publicly traded Viad conglomerate has been a great home to GES for decades and we are excited to start a new chapter as a private company with Truelink, who believes in our ability to continue delivering industry leadership, innovation and growth."

With over 2,600 employees and thousands of active union partners across the globe, GES and its companies have a decades-long history supporting the world's leading brands and events in robust business verticals, including healthcare, aerospace & defense, financial services, manufacturing, technology, and retail, in a variety of event marketing capacities.

"GES is a trusted brand with a proven track record of delivering best-in-class services to the global exhibitions and experiential marketing verticals. We look forward to collaborating with this talented team to help the company realize its full potential," Truelink's Co-Founder and Managing Partner Luke Myers said.

Included in the acquisition are GES Exhibitions, a major provider of global exhibitions & logistics services; Spiro, a leading global experiential agency; and onPeak, SHOWTECH, and Visit, which provide event accommodation, power/lighting and registration services. Upon closing, GES will become a privately-owned, stand-alone company within Truelink's business portfolio and continue to deliver a range of best-in-class and value enhancing experiential solutions to clients.

Derek Linde, current GES President, will assume the role of President and CEO following the closing. He will be joined by Jeff Quade, GES NA Exhibitions President; Jason Stead, GES EMEA Exhibitions President; and Jeff Stelmach, Spiro President, who will continue leading the operating businesses post transaction.

Linde continued, "We remain dedicated to delivering extraordinary experiences to our clients across the globe. This partnership with Truelink will enable us to intensify our focus on innovation and enhance our capabilities across our differentiated global platform."

About GES:

The GES business entity is a dynamic collective of industry-leading companies and their distinctive specialties-GES Exhibitions, Spiro, onPeak, SHOWTECH and Visit-that deliver comprehensive experiential, strategic, creative, event management and accommodation, meeting planning and logistical solutions, as well as registration and engagement solutions.?We?empower brands to engage their audiences and elevate customer experience, using?what we believe is today's?most powerful channel?in an ever-competitive landscape: experiential marketing. Whether?scaling?together or independently,?our companies strategically partner with brands and event organizers to?transform?business imperatives?into?measurable results that drive meaningful customer connections & bottom-line impact.

www.ges.com

www.thisisspiro.com

www.onpeak.com

www.showtech.ca

www.visitcloud.com

About Truelink Capital

Truelink Capital is a middle-market private equity firm based in Los Angeles. Truelink pairs deep industry experience in the industrials and technology-enabled services sectors with a commitment to building partnerships that drive long-term value through an operationally focused strategy. Truelink partners with management, corporate sellers, and founders to accelerate growth through the execution of strategic initiatives and transformative add-on acquisitions.

Contacts:
Marianne Szczech
630-220-6102
mszczech@ges.com

Photo - https://mma.prnewswire.com/media/2534737/GES_Collective.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/ges-to-be-acquired-by-truelink-capital-302280871.html

© 2024 PR Newswire
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.